Clinical Trial Update: Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR [Phase 3]

View source ↗

Summary

A Phase 3 trial is recruiting to compare Faricimab plus panretinal photocoagulation against vitrectomy with endolaser for proliferative diabetic retinopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Faricimab (faricimab)

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Proliferative Diabetic Retinopathy (PDR) | Phase 3 | Status: RECRUITING